Gueneuc A. auteur aut IRD Deloron Philippe auteur aut IRD Bertin Gwladys auteur aut IRD text journalArticle eng text/pdf reformatted digital access In most tropical areas, pregnant women are at increased risk of malaria, as a consequence of the massive sequestration of parasitized red blood cells in the placenta. The placenta plays a key role in embryonic and fetal development as well as in maternal-fetal exchanges, and pregnancy-associated malaria may alter selected placenta functions that lead to stillbirth and low birth weight. Although there are several tools (blood smear examination, RDT, PCR) to diagnose malaria infection during pregnancy, there is currently no test to assess placenta dysfunction in the framework of pregnancy-associated malaria. Pregnancy-associated malaria shares many features with preeclampsia, an extensively studied disease. Various biomarkers associated with placental dysfunction have been identified as associated with preeclampsia. Several of these are inflammatory markers that lack of specificity. A few seem more specific of placenta dysfunction, including s-endoglin and sFlt1, increased in the peripheral blood during preeclampsia. The predictive value of these biomarkers should be studied in the context of pregnancy-associated malaria to evaluate their usefulness in identifying placental dysfunction during malaria. These biomarkers should be considered to improve the diagnosis of placental dysfunction during malaria and pregnant women monitoring. specialized Biomarker Pregnancy malaria Preeclampsia AFRIQUE 052 050 16 art. 11 [7 p.] 2017 1475-2875 https://www.documentation.ird.fr/hor/fdi:010068827 10.1186/s12936-016-1664-0 1475-2875 [F B010068827] https://www.documentation.ird.fr/hor/fdi:010068827 https://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers17-01/010068827.pdf IRD - Base Horizon / Pleins textes 2017-02-06 2017-08-23 fdi:010068827 fre